Clinical characteristics of allergic bronchopulmonary mycosis caused by Schizophyllum commune
Tsuyoshi Oguma,Takashi Ishiguro,Katsuhiko Kamei,Jun Tanaka,Junko Suzuki,Akira Hebisawa,Yasushi Obase,Hiroshi Mukae,Takae Tanosaki,Shiho Furusho,Koji Kurokawa,Kentaro Watai,Hiroto Matsuse,Norihiro Harada,Ai Nakamura,Takuo Shibayama,Rie Baba,Kentaro Fukunaga,Hisako Matsumoto,Hisano Ohba,Susumu Sakamoto,Shinko Suzuki,Shintetsu Tanaka,Takahiro Yamada,Akira Yamasaki,Yuma Fukutomi,Yoshiki Shiraishi,Takahito Toyotome,Koichi Fukunaga,Terufumi Shimoda,Satoshi Konno,Masami Taniguchi,Katsuyoshi Tomomatsu,Naoki Okada,Koichiro Asano,Japan ABPM Research Program,
DOI: https://doi.org/10.1002/clt2.12327
2023-12-31
Clinical and Translational Allergy
Abstract:Abstract Background Allergic bronchopulmonary mycosis (ABPM) is an allergic disease caused by type I and type III hypersensitivity to environmental fungi. Schizophyllum commune , a basidiomycete fungus, is one of the most common fungi that causes non‐ Aspergillus ABPM. Objective Herein, we attempted to clarify the clinical characteristics of ABPM caused by S. commune (ABPM‐Sc) compared with those of allergic bronchopulmonary aspergillosis (ABPA). Methods Patients with ABPM‐Sc or ABPA were recruited from a nationwide survey in Japan, a multicenter cohort, and a fungal database at the Medical Mycology Research Center of Chiba University. The definition of culture‐positive ABPM‐Sc/ABPA is as follows: (1) fulfills five or more of the 10 diagnostic criteria for ABPM proposed by Asano et al., and (2) positive culture of S. commune/Aspergillus spp. in sputum, bronchial lavage fluid, or mucus plugs in the bronchi. Results Thirty patients with ABPM‐Sc and 46 with ABPA were recruited. Patients with ABPM‐Sc exhibited less severe asthma and presented with better pulmonary function than those with ABPA ( p = 0.008–0.03). Central bronchiectasis was more common in ABPM‐Sc than that in ABPA, whereas peripheral lung lesions, including infiltrates/ground‐glass opacities or fibrotic/cystic changes, were less frequent in ABPM‐Sc. Aspergillus fumigatus ‐specific immunoglobulin (Ig)E was negative in 10 patients (34%) with ABPM‐Sc, who demonstrated a lower prevalence of asthma and levels of total serum IgE than those with ABPM‐Sc positive for A. fumigatus ‐specific IgE or ABPA. Conclusions Clinical characteristics of ABPM‐Sc, especially those negative for A. fumigatus ‐specific IgE, differed from those of ABPA.
allergy